Stocktoria
Guardant Health, Inc. GH
Guardant Health, Inc. statistics & valuation
Market cap$19.8B
P / S20.1×
Net margin-42.4%
FCF margin-23.7%
Net debt$1.1B
Enterprise value USD$20.9B
Earnings yield EBIT/EV-2.1%
Return on capital-25.6%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -44.5% | -60.0% | -100.1% | -121.1% | -110.0% | -88.9% | -38.4% | -102.5% | -153.7% |
| Net margin | -42.4% | -59.0% | -85.0% | -145.6% | -103.0% | — | -35.3% | -93.8% | -167.0% |
| FCF margin | -23.7% | -37.2% | -61.3% | -86.1% | -76.0% | -48.9% | -30.7% | -101.9% | -158.3% |
| Return on assets | -20.7% | -29.4% | -26.8% | -40.7% | -17.5% | — | -7.9% | -14.5% | -24.3% |
| Return on equity | 419.2% | 312.5% | -302.1% | -1087.7% | -59.7% | — | -9.5% | -17.6% | -27.0% |
| Debt / equity | -15.14× | -8.18× | — | — | — | — | — | — | — |
| Current ratio | 4.84 | 4.68 | 6.54 | 6.17 | 5.72 | 28.27 | 8.21 | 9.99 | 12.38 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.